Skip to main content

VRG Therapeutics

Budapest, Hungary

VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.

$5.5M raised
Aug 2023
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VRG Therapeutics

How much funding has VRG Therapeutics raised?
VRG Therapeutics has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Who are VRG Therapeutics's investors?
VRG Therapeutics's investors include Széchenyi Capital Fund Management, The Vascular Group.
Where is VRG Therapeutics headquartered?
VRG Therapeutics is headquartered in Budapest, Hungary.
What does VRG Therapeutics do?
VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
What stage is VRG Therapeutics at?
VRG Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"VRG Therapeutics — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/vrg-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). VRG Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vrg-therapeutics
Wikipedia (cite web)
{{cite web |title=VRG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vrg-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .